Rapid improvement of refractory generalized granuloma annulare with the Janus kinase inhibitor baricitinib in two patients
Dong Chan Kim, Hee Young Kang
Abstract
We report the results from baricitinib treatment in two patients with refractory generalized granuloma annulare. We highlight that baricitinib could be a plausible treatment option as a new molecular-targeted therapy for refractory generalized granuloma annulare.
Topics & Concepts
Refractory (planetary science)Granuloma annulareMedicineDermatologyMaterials scienceComposite materialSkin Diseases and DiabetesGenetic and rare skin diseases.Inflammatory Myopathies and Dermatomyositis